Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shrushti Shah
Observed names:
S.S. Shah,
Shah, Shrushti
Institutions:
University of Illinois Urbana-Champaign,
University of Illinois System
Observed institutions:
University of Illinois Urbana-Champaign,
University of Illinois System,
University of Illinois Chicago, Rockford campus,
STATinMED (United States),
Bharati Vidyapeeth (Deemed to be University)
ORCID:
0000-0002-0169-9816
Observed ORCID:
0000-0002-0169-9816
OpenAlex ID:
A5101959345
The application of artificial intelligence: perceptions from healthcare professionals
2023
·
Aishwarya Sonawane
, Shrushti Shah
, et al.
·
Health and Technology
·
17
Comparative Efficacy of Hand Disinfection Potential of Hand Sanitizer and Liquid Soap among Dental Students: A Randomized Controlled Trial
2020
·
G Anitha
, Mahesh R Khairnar
, et al.
·
Indian Journal of Critical Care Medicine
·
14
PDF
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer
2023
·
Alexander Cohen
, Virginia Noxon
, et al.
·
Thrombosis Research
·
10
Risk Factors of Musculoskeletal Problems among Dental Professionals in a Dental Institute: A Cross-sectional Survey
2021
·
Mahesh R Khairnar
, Umesh Wadgave
, et al.
·
World Journal of Dentistry
·
8
PDF
Health disparities in psoriasis: geographic barriers to access in the United States
2024
·
Lauren Seigel
, Sofia Shoaib
, et al.
·
Journal of Dermatological Treatment
·
5
Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer
2023
·
Amol D. Dhamane
, Shrushti Shah
, et al.
·
Thrombosis Research
·
5
Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease
2024
·
Alexander T. Cohen
, Virginia Noxon
, et al.
·
Current Medical Research and Opinion
·
2
Effectiveness and Safety of Anticoagulants Among Patients with Venous Thromboembolism and Common Cancers or Cancers with High Venous Thromboembolism Risk
2024
·
Alexander T Cohen
, Virginia Noxon
, et al.
·
Future Oncology
·
1
PDF
Abstract No. 298: Efficacy and safety of the Mynx closure device in high risk chemoembolization patients
2011
·
C.F. Giordano
, S.S. Shah
, et al.
·
Journal of Vascular and Interventional Radiology
·
1
Abstract No. 208: Single center experience with drug eluting stents for infrapopliteal occlusive disease in patients with critical limb ischemia
2010
·
A.M. Fischman
, S.S. Shah
, et al.
·
Journal of Vascular and Interventional Radiology
·
1
PDF
Combination Treatment with NCX 4040 and Napabucasin Triggers Enhanced Oxidative Stress, STAT3 Inhibition and Plausible Immunogenic Activation in Metastatic Prostate Cancer Cells
2025
·
Nishtha Pathak
, Shrushti Shah
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 956: NCX 4040 and napabucasin synergistically inhibits stemness in human prostate cancer (PCa) cellular models and potently targets transgenic murine PCa cells via inducing oxidative stress
2024
·
Shrushti Shah
, Gnanasekar Munirathinam
·
Cancer Research
Show more works
View as search
Works count:
17
Citation count:
65
H-index:
5
I10-index:
3
Year
Topic
Type